Gemopatrilat
Gemopatrilat
Gemopatrilat (pronunciation: /ʤɛmoʊpætrɪlæt/) is a vasopeptidase inhibitor that is primarily used in the treatment of hypertension and heart failure.
Etymology
The term "Gemopatrilat" is derived from the combination of two words: "Gem" which is a prefix often used in pharmaceutical nomenclature to denote a geminal substituent, and "patrilat" which is a suffix used to denote a vasopeptidase inhibitor.
Usage
Gemopatrilat is used in the treatment of hypertension and heart failure. It works by inhibiting the action of vasopeptidase, an enzyme that breaks down certain peptides in the body that are involved in regulating blood pressure and fluid balance.
Related Terms
- Vasopeptidase inhibitor: A class of drugs that inhibit the action of vasopeptidase, an enzyme that breaks down certain peptides in the body that are involved in regulating blood pressure and fluid balance.
- Hypertension: A condition characterized by consistently high blood pressure.
- Heart failure: A condition in which the heart is unable to pump enough blood to meet the body's needs.
See Also
External links
- Medical encyclopedia article on Gemopatrilat
- Wikipedia's article - Gemopatrilat
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski